Skip to main content
. 2022 Sep;22(3):145–154. doi: 10.4314/ahs.v22i3.17

Table 2.

Clinical Characteristics of patients and controls.

Variables Groups Case Control P Value
Menarche 12–13 53 (30.1%) 63 (35.8%) 0.51
14–15 33 (18.8%) 21 (11.9%)
16–18 2 (1.1%) 4 (2.3%)
Age at Menopause N/A 45 (25.6%) 34 (19.3%) 0.18
41–50 35 (19.9%) 34 (19.3%)
51–60 7 (4.0%) 20 (11.4%)
61+ 1 (0.6%) 0 (0.0%)
Age at First Pregnancy No Pregnancy 3 (1.7%) 7 (4.0%) 0.42
14–19 47 (26.7%) 46 (26.1%)
20–25 28 (15.9%) 28 (15.9%)
26–31 10 (5.7%) 7 (4.0%)
No of Children No Child 7 (4.0%) 9 (5.1%) 0.663
1–3 20 (11.4%) 23 (13.1%)
4–6 39 (22.2%) 30 (17.0%)
7–9 16 (9.1%) 21 (11.9%)
10–12 6 (3.4%) 5 (2.8%)
Duration of Breast Feeding Below 1 Yr 10 (5.7%) 15 (8.5%) 0.233
1–2 Yr 55 (31.3%) 44 (25.0%)
2–3 Yr 23 (13.1%) 29 (16.5%)
Enlargement of Breast No Increase 23 (13.1%) 69 (39.2%) 0.000
Gradual Increase 53 (30.1%) 18 (10.2%)
Rapid Increase 12 (6.8%) 0 (0.0%)
Breast Ulceration Yes 11 (6.3%) 0 (0.0%) 0.320
No 77 (43.8%) 81 (46.0%)
Cyclical Pain No Pain 33 (18.8%) 69 (39.2%) 0.000
Cyclical Pain 24 (13.6%) 13 (7.4%)
Acyclical Pain 21 (11.9%) 3 (1.7%)
Other Pain 10 (5.7%) 3 (1.7%)
Mobility Non Mobile 36 (20.5%) 3 (1.7%) 0.000
Mobile 52 (29.5%) 85 (48.3%)
Tenderness No 50 (28.4%) 86 (48.9%) 0.000
On Self Palpation 28 (15.9%) 0 (0.0%)
On Deep Palpation 10 (5.7%) 1 (0.6%)
Peaudorange No/Normal 57 (32.4%) 88 (50.0%) 0.000
Present 31 (17.6%) 0 (0.0%)
Nipple Discharge No Discharge 69 (39.2%) 88 (50.0%) 0.000
Discharge 19 (10.8%) 0 (0.0%)
Lymphedema No Edema 67 (38.1%) 88 (50.0%) 0.000
Edema 21 (11.9%) 0 (0.0%)
Weight Loss No Loss 68 (38.6%) 88 (50.0%) 0.000
Weight Loss 20 (11.4%) 0 (0.0%)
Liver Changes No Change 60 (34.1%) 88 (50.0%) 0.000
Degenerative
Changes
19 (10.8%) 0 (0.0%)
Fatty/Enlarged 9 (5.1%) 0 (0.0%)